Jie Xu
30Patents
7h-index
103Co-inventors
72Inventor score
Filing activity: Oct 13, 1995 → Feb 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7973013B2 | 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment | Chemistry; Metallurgy | 107 | Active |
| US8012941B2 | Carba-nucleoside analogs for antiviral treatment | Emerging Cross-Sectional Technologies | 99 | Active |
| US8012942B2 | Carba-nucleoside analogs for antiviral treatment | Emerging Cross-Sectional Technologies | 93 | Active |
| US6004782A | Hyperexpression of bioelastic polypeptides | Chemistry; Metallurgy | 36 | Expired |
| US10023600B2 | Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs | Human Necessities | 35 | Active |
| US10988498B2 | Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs | Human Necessities | 27 | Active |
| US5854387A | Simple method for the purification of a bioelastic polymer | Chemistry; Metallurgy | 21 | Expired |
| US10954234B2 | Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use | Chemistry; Metallurgy | 5 | Active |
| US10774053B2 | HIV protease inhibitors | Human Necessities | 4 | Active |
| US10774071B2 | PD-1/PD-L1 inhibitors | Chemistry; Metallurgy | 3 | Active |
| US11352329B2 | HIV protease inhibitors | Human Necessities | 3 | Active |
| US10710986B2 | PD-1/PD-L1 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US11845723B2 | Diacylglycerol kinase modulating compounds | Chemistry; Metallurgy | 1 | Active |
| US11555029B2 | PD-1/PD-L1 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11236085B2 | PD-1/PD-L1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11780834B2 | Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3-fluoropropyl)azetidin-3- yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use | Chemistry; Metallurgy | 0 | Active |
| US11926628B2 | Diacylglyercol kinase modulating compounds | Chemistry; Metallurgy | 0 | Active |
| US11647737B2 | Genetically modified rabbit expressing an exogenous protein in milk | Chemistry; Metallurgy | 0 | Active |
| US12018297B2 | Nuclease-mediated nucleic acid modification | Chemistry; Metallurgy | 0 | Active |
| US11976072B2 | Diacylglycerol kinase modulating compounds | Chemistry; Metallurgy | 0 | Active |
| US12338233B2 | PD-1/Pd-L1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11008552B2 | Multicopper oxidase mutant with improved salt tolerance | Chemistry; Metallurgy | 0 | Active |
| US11873305B2 | Processes for synthesis of substituted indole intermediates for the synthesis of serd compounds | Chemistry; Metallurgy | 0 | Active |
| US12071422B2 | Process for synthesis of quinazoline compounds | Performing Operations; Transporting | 0 | Active |
| US9475790B2 | Method for preparing refined lactide from recovered polylactic acid | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.